359
Views
7
CrossRef citations to date
0
Altmetric
Research Article

DNA methylation analysis in rat kidney epithelial cells exposed to 3-MCPD and glycidol

, &
Pages 432-439 | Received 25 Sep 2015, Accepted 30 Oct 2016, Published online: 24 Nov 2016

References

  • Alley MC, Scudiere DA, Monks A, et al. (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601.
  • Baccarelli A, Bollati V. (2009). Epigenetics and environmental chemicals. Curr Opin Pediatr 21:243–251.
  • Barocelli E, Corradi A, Mutti A, Petronini P. (2011). Scientific report submitted to EFSA. Comparison between 3-MCPD and its palmitic esters in a 90-day toxicological study. 1–131.
  • Baylin SB, Herman JG, Graff JR, et al. (1998). Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141–196.
  • Bombail V, Moggs JG, Orphanides G. (2004). Perturbation of epigenetic status by toxicants. Toxicol Lett 149:51–58.
  • Borenfreund E, Borrero O. (1984). In vitro cytotoxicity assays. Potential alternatives to the Draize ocular allergy test. Cell Biol Toxicol 1:55–65.
  • Buhrke T, Frenzel F, Kuhlmann J, Lampen A. (2014). 2-Chloro-1, 3-propanediol (2-MCPD) and its fatty acid esters: cytotoxicity, metabolism, and transport by human intestinal Caco-2 cells. Arch Toxicol 89:2243–2251. doi:10.1007/s00204-014-1395-3.
  • Cho WS, Han BS, Nam KT, et al. (2008). Carcinogenicity study of 3-monochloropropane-1,2-diol in Sprague-Dawley rats. Food Chem Toxicol 46:3172–3177.
  • Demirel G, Alpertunga B, Ozden S. (2015). Role of fumonisin B1 on DNA methylation changes in rat kidney and liver cells. Pharm Biol 53:1302–1310.
  • El Ramy R, Ould Elhkim M, Lezmi S, Poul JM. (2007). Evaluation of the genotoxic potential of 3-monochloropropane-1,2-diol (3-MCPD) and its metabolites, glycidol and beta-chlorolactic acid, using the single cell gel/comet assay. Food Chem Toxicol 45:41–48.
  • Esteller M. (2002). CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427–5440.
  • Fragou D, Fragou A, Kouidou S, et al. (2011). Epigenetic mechanisms in metal toxicity. Toxicol Mech Methods 21:343–352.
  • Frei H, Würgler FE. (1997). The vicinal chloroalcohols 1,3-dichloro-2-propanol (DC2P), 3-chloro-1,2-propanediol (3CPD) and 2-chloro-1,3-propanediol (2CPD) are not genotoxic in vivo in the wing spot test of Drosophila melanogaster. Mutat Res 394:59–68.
  • Goodman JI, Watson RE. (2002). Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu Rev Pharmacol Toxicol 42:501–525.
  • Hamlet CG, Jayaratne SM, Matthews W. (2002). 3-Monochloropropane-1, 2-diol (3- MCPD) in food ingredients from UK food producers and ingredient suppliers. Food Addit Contam 19:15–21.
  • Henderson LM, Bosworth HJ, Ransome SJ, et al. (1987). An assessment of the mutagenic potential of 1,3-dichloro-2-propanol, 3-chloro-1,2-propanediol and a cocktail of chloropropanols using the mouse lymphoma TK locus assay. Unpublished report no. ULR 130 ABC/861423 from Huntingdon Research Centre Ltd, Huntingdon, Cambridgeshire, UK.
  • Herman JG, Graff JR, Myöhänen SBDN, et al. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–9826.
  • Hwang M, Yoon E, Kim J, et al. (2009). Toxicity value for 3-monochloropropane-1,2-diol using a benchmark dose methodology. Regul Toxicol Pharmacol 53:102–106.
  • International Agency for Research on Cancer (IARC). (2000). Glycidol. In: Some industrial chemicals. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans, vol. 77. Lyon, France: WHO Press, 469–486.
  • International Agency for Research on Cancer (IARC). (2012). MCPD. In: Some chemicals present in industrial and consumer products. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 101. Lyon, France: WHO Press, 349–374.
  • Joint FAO/WHO Expert Committee on Food Additives (JECFA). (2002). 3-Chloro-1,2-propanediol. WHO Food Add. Ser. 48. Geneva: WHO, 401–432.
  • Joint MAFF/DH Food Safety and Standards Group (JFSSG). (1999). Survey of 3-monochloropropane-1, 2-diol (3-MCPD) in acid hydrolyzed vegetable protein. Food surveillance information sheet no. 181
  • Jones AR, Gadiel P, Stevenson D. (1981). The fate of oxalic acid in the Wistar rat. Xenobiotica 11:385–390.
  • Jones PA, Baylin SB. (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428.
  • Kim K, Song C, Park Y, et al. (2004). 3-Monochloropropane-1,2-diol does not cause neurotoxicity in vitro or neurobehavioral deficits in rats. Neurotoxicology 25:377–385.
  • Klaunig JE, Kamendulis LM, Xu Y. (2000). Epigenetic mechanisms of chemical carcinogenesis. Hum Exp Toxicol 19:543–555.
  • Koturbash I, Beland FA, Pogribny IP. (2011). Role of epigenetic events in chemical carcinogenesis – a justification for incorporating epigenetic evaluations in cancer risk assessment. Toxicol Mech Methods 21:289–297.
  • LeBaron MJ, Rasoulpour RJ, Klapacz J, et al. (2010). Epigenetics and chemical safety assessment. Mutat Res 705:83–95.
  • Li LC, Dahiya R. (2002). MethPrimer: designing primers for methylation PCRs. Bioinformatics 18:1427–1431.
  • Liu M, Gao BY, Qin F, et al. (2012). Acute oral toxicity of 3-MCPD mono- and di-palmitic esters in Swiss mice and their cytotoxicity in NRK-52E rat kidney cells. Food Chem Toxicol 50:3785–3791.
  • Liu WB, Ao L, Zhou ZY, et al. (2010). CpG island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine. Biochem Biophys Res Commun 402:507–514.
  • Lynch BS, Bryant DB, Hook GJ, et al. (1998). Carcinogenicity of monochloro-1,2-propanediol (alpha-chlorohydrin, 3-MCPD). Int J Toxicol 17:947–976.
  • Methyl Primer Express Software 1. (2006). Applied biosystems (designed and created by Fraga MF, Ferrero C, Esteller M).
  • Moggs JG, Goodman JI, Trosko JE, Roberts RA. (2004). Epigenetics and cancer: implications for drug discovery and safety assessment. Toxicol Appl Pharmacol 196:422–430.
  • Niwa T, Yamashita S, Tsukamoto T, et al. (2005). Whole-genome analyses of loss of heterozygosity and methylation analysis of four tumor-suppressor genes in N-methyl-N0-nitro-N-nitrosoguanidine-induced rat stomach ca1rcinomas. Cancer Sci 96:409–413.
  • NTP. (1990). National Toxicology Program, Toxicology and carcinogenesis studies of glycidol (CAS No. 556-52-5) in F344/N rats and B6C3F1 mice (gavage studies). Technical report series no. 374. Research Triangle Park, NC: National Institutes of Health Publication No. 90-2829.
  • Onami S, Cho YM, Toyoda T, et al. (2014). Absence of in vivo genotoxicity of 3-monochloropropane-1,2-diol and associated fatty acid esters in a 4-week comprehensive toxicity study using F344 gpt delta rats. Mutagenesis 29:295–302.
  • Peng X, Gan J, Wang Q, et al. (2016). 3-Monochloro-1,2-propanediol (3-MCPD) induces apoptosis via mitochondrial oxidative phosphorylation system impairment and the caspase cascade pathway. Toxicology.doi: 10.1016/j.tox.2016.09.017. [Epub Ahead of Print].
  • Pogribny IP, Rusyn I, Beland FA. (2008). Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents. Environ Mol Mutagen 49:9–15.
  • Rasoulpour RJ, LeBaron MJ, Ellis-Hutching RG, et al. (2011). Epigenetic screening in product safety assessment: are we there yet? Toxicol Mech Methods 21:298–311..
  • Repetto G, del Peso A, Zurita JL. (2008). Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 3:1125–1131.
  • Robjohns S, Marshall R, Fellows M, Kowalczyk G. (2003). In vivo genotoxicity studies with 3-monochloropropan-1,2-diol. Mutagenesis 18:401–404.
  • Rossi AM, Migliore L, Lascialfari D, et al. (1983). Genotoxicity, metabolism and blood kinetics of epichlorohydrin in mice. Mutat Res 118:213–226.
  • Sancak D, Ozden S. (2015). Global histone modifications in fumonisin B1 exposure in rat kidney epithelial cells. Toxicol in Vitro 29:1809–1815.
  • Scientific Committee on Food (SCF). (2001). Opinion on 3-monochloro-propane-1,2-diol (3-MCPD), updating the SCF opinion of 1994 adopted on 30 May 2001. Brussels: European Commission.
  • Silhankova L, Smid F, Cerna M, et al. (1982). Mutagenicity of glycerol chlorohydrines and of their esters with higher fatty acids present in protein hydrolysates. Mutat Res 103:77–81.
  • Stolzenberg SJ, Hine CH. (1980). Mutagenicity of 2- and 3-carbon halogenated compounds in the Salmonella/mammalian-microsome test. Environ Mutagen 2:59–66.
  • Sun J, Bai S, Bai W, et al. (2013). Toxic mechanisms of 3-monochloropropane-1,2-diol on progesterone production in R2C rat leydig cells. J Agric Food Chem 61:9955–9960.
  • Sunahara G, Perrin I, Marchessini M. (1993). Carcinogenicity study on 3-monochloro propane 1, 2,-diol (3-MCPD) administered in drinking water to Fischer 344 rats. Report no RE-SR93003 Nestec Ltd. Research and Development Switzerland.
  • Swafford DS, Middleton SK, Palmisano WA, et al. (1997). Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol Cell Biol 17:1366–1374.
  • Van Meerloo J, Kaspers GJ, Cloos J. (2011). Cell sensitivity assays: the MTT assay. In: Cancer cell culture. Humana Press, 237–245.
  • Watson RE, Goodman JI. (2002). Effects of phenobarbital on DNA methylation in GC-rich regions of hepatic DNA from mice that exhibit different levels of susceptibility to liver tumorigenesis. Toxicol Sci 68:51–58.
  • Zeiger E, Anderson B, Haworth S, et al. (1988). Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ Mol Mutagen 11:1–157.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.